wookster said:
Here is a similar site which includes Hair On My Shoulders, I mean Head and Shoulders:
http://www.rense.com/general63/nerv.htm
Post reputable scientific studies, not unattributed scare stories on sites maintained by American conspiracy theorists.
BTW, way to ignore the two real studies on the beneficial effects of Nizoral.
EDIT -
Final report on the safety assessment of methylisothiazoline and methylchloroisothiazolinone
J Am Coll Toxicol Vol:11, 1 (1992) pp 75-128
Abstract:
Methylisothiazolinone and Methylchloroisothiazolinone (MI/MCI) are heterocyclic organic compounds that are used in cosmetics as a broad spectrum preservative system. MI/MCI was absorbed after oral administration and then was excreted in the urine or feces; storage is the tissue was minimal. Up to 63% of a single percutaneous dose was bound to the site of application 24 hours after exposure. The MI/MCI-CG bound to the skin had a 13.1-day half-life. MI/MCI was moderately to highly toxic to rats, and highly toxic to rabbits when administered orally, and moderately toxic when applied dermally. MI/MCI was not a cumulative ocular irritant when tested at 55 ppm. The dermal irritation of MI/MCI was concentration dependent but nonirritating to rabbit skin at 560 ppm concentrations; this nonirritating concentration is well above the maximum recommended use concentration. No treatment-related effects were observed in rats which received MI/MCI in oral doses up to 25.5 mg/kg/day for 2 week. Doses of MI/MCI up to 2.8 mg/kg/day applied dermally to rabbits, 5 days per week for 3 weeks, produced moderate irritation at the application site but no systemic toxicity. Dermal application of MI/MCI at doses up to 0.4 mg/kg/day for 3 months produced no systemic toxicity in rabbits. No toxicologically significant treatment-related effects were observed in rats or dogs at doses up to 30 and 28 mg/kg/day, respectively. The result of genotoxic testing of MI/MCI varied with the assay used. Dermal application of 400 ppm MI/MCI-CG, 3 times per week for 30 months, had no local or systemic tumorigenic effect in male mice. MI/MCI administered by gavage to pregnant rabbits and rats at doses up to 13.3 mg/kg/day was toxic to the dam, embryo, and fetus; the compound was not teratogenic. MI/MCI is a sensitizer however, the concentration of MI/MCI in cosmetic products which produced sensitization varies. The available human sensitization test data at concentrations of 50 ppm and above are not in agreement. MI/MCI-CG was not a sensitizer or photosensitizer at a concentration of 15 ppm.
It is concluded that Methylisothiazolinone/Methylchloroiso- thiazolinone may be safely used in "rinse-off" products at a concentration not to exceed 15 ppm and in "leave-on" cosmetic products at a concentration not to exceed 7.5 ppm. The stated safe use concentration refers to a mixture containing 23.3% Methylisothiazolinone and 76.7% Methylchloroisothiazolinone.